Gor Alpa Pragnesh, Saksena Miti
Department of Pharmacology, Pramukh Swami Medical College, Gokalnagar, Karamsad 388 325, Anand, Gujarat, India.
J Pharmacol Pharmacother. 2011 Jan;2(1):26-9. doi: 10.4103/0976-500X.77104.
To identify the ADRs due to NSAIDs and to know how to monitor the drug's effect.
A descriptive study was undertaken in the Orthopedic Outpatients Department of a tertiary care teaching hospital. Hundred patients were enrolled in this study to observe the risk of adverse drug reactions (ADRs) due to NSAIDs. All the ADRs were further analyzed in relation to age and sex, type of drug and its pattern. Probability scale was used for the causality assessment of the ADRs.
26% of the 100 patients developed ADR due to NSAIDs. There was not much of a difference in the number of the ADRs in relation to the gender. Diclofenac was the highest prescribed drug (65 patients), followed by paracetamol (12), nimesulide (10), ibuprofen (6), piroxicam (5) and Etoricoxib (2). Diclofenac accounted for the maximum number (73%) of ADRs, followed by nimesulide (16%), paracetamol (7%), and Etoricoxib (4%).
Pharmacovigilance improves recognition of ADRs by the medical students. It allows the treating physician to identify the ADR associated with drugs, in particular, with the ones considered relatively safe and with those commonly prescribed by the medical and non-health professionals.
识别非甾体抗炎药引起的不良反应,并了解如何监测药物效果。
在一家三级护理教学医院的骨科门诊进行了一项描述性研究。本研究纳入了100名患者,以观察非甾体抗炎药引起药物不良反应(ADR)的风险。所有不良反应均根据年龄、性别、药物类型及其模式进行进一步分析。采用概率量表对不良反应进行因果关系评估。
100名患者中有26%因非甾体抗炎药出现不良反应。不良反应的数量在性别方面差异不大。双氯芬酸是处方量最高的药物(65例患者),其次是对乙酰氨基酚(12例)、尼美舒利(10例)、布洛芬(6例)、吡罗昔康(5例)和依托考昔(2例)。双氯芬酸导致的不良反应数量最多(73%),其次是尼美舒利(16%)、对乙酰氨基酚(7%)和依托考昔(4%)。
药物警戒提高了医学生对不良反应的认识。它使治疗医生能够识别与药物相关的不良反应,特别是与那些被认为相对安全以及医学和非卫生专业人员常用的药物相关的不良反应。